David Kereiakes Joins AO Foundation Board to Foster Surgical Innovation and Improved Patient Outcomes
On May 11, 2026, the AO Foundation, a leading organization dedicated to advancing surgical care for trauma and musculoskeletal disorders, announced the appointment of David Kereiakes as a member of its Technology Transfer Board. Kereiakes, who serves as the managing partner at Windham Capital Partners, brings with him substantial expertise in commercialization strategies and investment within the medical technology sector. This collaboration aims to bridge the gap between innovative medical solutions and the patients who require them.
The AO Foundation, recognized for its rigorous evidence-based approach, functions on a global scale, supporting over half a million healthcare professionals in more than 160 countries. This vast network represents a unique opportunity to ensure that cutting-edge surgical innovations reach the surgeons and patients who need them most. The Technology Transfer Board specifically intends to facilitate the translation of scientifically validated innovations into practical applications that can be adopted within clinical settings.
Kereiakes's career spans over 15 years in the orthopedic and trauma investing field, during which he has successfully managed investments that have led to significant exits. His previous roles include backing innovative startups like PainTEQ and OrthAlign, which have made strides in bringing advanced technologies to a broader patient population. Through these efforts, Kereiakes has consistently demonstrated a commitment to improving patient access to high-quality medical treatments, aligning well with the mission of the AO Foundation.
Commenting on his new role, Kereiakes emphasized the importance of evidence-based research in advancing musculoskeletal care. He stated, 'The AO is the gold standard not only in reputation but due to its substantial contributions to patient care over the last sixty years. Joining this board offers a platform to further my passion for ensuring that validated technologies are accessible to the physicians who rely on them daily.'
Roland Herzog, Executive Director of the Innovation Translation Center at AO Foundation, welcomed Kereiakes, noting his significant experience will enhance the efforts of the board. Herzog remarked, 'David brings critical clinical domain knowledge and commercial acumen to our mission, enhancing our effectiveness for the benefit of surgeons and patients around the world.'
Kereiakes's background includes a pivotal role at Providence Ventures, where he contributed to shaping one of the largest nonprofit health systems in the United States. His leadership as president of the Mid-America Health Investors Network showcases his extensive experience in healthcare investments.
As the medical community continues to face persistent challenges in converting the latest innovations into practical solutions, the AO Foundation and David Kereiakes aim to change the narrative, ensuring that advancements in surgical care positively impact patients across the globe. Through its broad educational initiatives and commitment to research, the foundation remains at the forefront of improving surgical practices and patient outcomes.
For more information about the AO Foundation and its numerous educational events and initiatives, visit their official website. Similarly, Windham Capital Partners focuses on investing in companies at the intersection of medical technology, digital health, and artificial intelligence, striving to enhance clinical outcomes and expand access to superior healthcare.
This appointment symbolizes a joint effort to address the critical needs in surgical innovation and patient care, and highlights the undeniable synergy between investment strategy, clinical practice, and innovative medical technologies.
The AO Foundation, recognized for its rigorous evidence-based approach, functions on a global scale, supporting over half a million healthcare professionals in more than 160 countries. This vast network represents a unique opportunity to ensure that cutting-edge surgical innovations reach the surgeons and patients who need them most. The Technology Transfer Board specifically intends to facilitate the translation of scientifically validated innovations into practical applications that can be adopted within clinical settings.
Kereiakes's career spans over 15 years in the orthopedic and trauma investing field, during which he has successfully managed investments that have led to significant exits. His previous roles include backing innovative startups like PainTEQ and OrthAlign, which have made strides in bringing advanced technologies to a broader patient population. Through these efforts, Kereiakes has consistently demonstrated a commitment to improving patient access to high-quality medical treatments, aligning well with the mission of the AO Foundation.
Commenting on his new role, Kereiakes emphasized the importance of evidence-based research in advancing musculoskeletal care. He stated, 'The AO is the gold standard not only in reputation but due to its substantial contributions to patient care over the last sixty years. Joining this board offers a platform to further my passion for ensuring that validated technologies are accessible to the physicians who rely on them daily.'
Roland Herzog, Executive Director of the Innovation Translation Center at AO Foundation, welcomed Kereiakes, noting his significant experience will enhance the efforts of the board. Herzog remarked, 'David brings critical clinical domain knowledge and commercial acumen to our mission, enhancing our effectiveness for the benefit of surgeons and patients around the world.'
Kereiakes's background includes a pivotal role at Providence Ventures, where he contributed to shaping one of the largest nonprofit health systems in the United States. His leadership as president of the Mid-America Health Investors Network showcases his extensive experience in healthcare investments.
As the medical community continues to face persistent challenges in converting the latest innovations into practical solutions, the AO Foundation and David Kereiakes aim to change the narrative, ensuring that advancements in surgical care positively impact patients across the globe. Through its broad educational initiatives and commitment to research, the foundation remains at the forefront of improving surgical practices and patient outcomes.
For more information about the AO Foundation and its numerous educational events and initiatives, visit their official website. Similarly, Windham Capital Partners focuses on investing in companies at the intersection of medical technology, digital health, and artificial intelligence, striving to enhance clinical outcomes and expand access to superior healthcare.
This appointment symbolizes a joint effort to address the critical needs in surgical innovation and patient care, and highlights the undeniable synergy between investment strategy, clinical practice, and innovative medical technologies.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.